NSPR Company Background InspireMD, Inc. is a
Post# of 5789
Posted On: 09/01/2016 6:02:25 AM
NSPR
Company Background
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet mesh and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard coronary product, MGuard Prime Embolic Protection System (MGuard Prime EPS), is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter.
http://www.inspiremd.com/
Company Background
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet mesh and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard coronary product, MGuard Prime Embolic Protection System (MGuard Prime EPS), is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter.
http://www.inspiremd.com/
(0)
(0)